M.A. Balabanova
Research Subjects
M.A. Balabanova has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Mikhail Gur'EVich Poluektov
Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - N. A. Gorbachev
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Anastasia Zakharova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication
Latest Publications
- 10 June 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (5) , 55-62
Pharmacological and non-pharmacological treatment for narcolepsy
This paper presents an overview of current pharmacological and non-pharmacological treatment options available for narcolepsy. Antidepressant medications, including selective serotonin reuptake inhibitors and selective serotonin and norepinephrine reuptake inhibitors, have demonstrated efficacy in mitigating cataplexy episodes. Additionally, various pharmaceutical agents, including psychostimulants and anesthetics, are effective in alleviating excessive daytime sleepiness. Among the behavioral interventions for narcolepsy, adherence to a consistent sleep schedule and the incorporation of scheduled naps throughout the day remain the most widely implemented strategies.
- 10 June 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (5) , 55-62
Pharmacological and non-pharmacological treatment for narcolepsy
This paper presents an overview of current pharmacological and non-pharmacological treatment options available for narcolepsy. Antidepressant medications, including selective serotonin reuptake inhibitors and selective serotonin and norepinephrine reuptake inhibitors, have demonstrated efficacy in mitigating cataplexy episodes. Additionally, various pharmaceutical agents, including psychostimulants and anesthetics, are effective in alleviating excessive daytime sleepiness. Among the behavioral interventions for narcolepsy, adherence to a consistent sleep schedule and the incorporation of scheduled naps throughout the day remain the most widely implemented strategies.
- 19 November 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (10) , 7-11
Current issues of diagnosis and therapy of patients with restless legs syndrome
Current issues in the management of patients with restless legs syndrome are presented. For a clearer understanding of the disease pathogenesis, insights into well-studied components of pathophysiology are provided. The diagnosis is based on criteria developed and published by the International Restless Legs Syndrome Study Group in 2014. Despite the rapid and significant reduction in disease symptoms achieved during pharmacotherapy, tailoring an optimal treatment regimen remains a challenging clinical task, especially in elderly patients due to prolonged use of drugs and, as a result, the low effectiveness of pathogenetic therapy. To improve the condition, it is permitted to divide the daily dose of the drug or discontinue it and replace it with an agent from a different group. Several studies suggested non-drug methods as adjunctive therapy.
- 19 November 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (10) , 7-11
Current issues of diagnosis and therapy of patients with restless legs syndrome
Current issues in the management of patients with restless legs syndrome are presented. For a clearer understanding of the disease pathogenesis, insights into well-studied components of pathophysiology are provided. The diagnosis is based on criteria developed and published by the International Restless Legs Syndrome Study Group in 2014. Despite the rapid and significant reduction in disease symptoms achieved during pharmacotherapy, tailoring an optimal treatment regimen remains a challenging clinical task, especially in elderly patients due to prolonged use of drugs and, as a result, the low effectiveness of pathogenetic therapy. To improve the condition, it is permitted to divide the daily dose of the drug or discontinue it and replace it with an agent from a different group. Several studies suggested non-drug methods as adjunctive therapy.